Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia

Clinica Chimica Acta

Volumn 366, Issue 1-2, 2006, Pages 269-273

  Li, Jian Jun ^a   Li, Yi Shi ^a   Chu, Jian Ming ^a   Zhang, Chao Yang ^a   Wang, Ying ^a   Huang, Yuan ^a   Chen, Jue ^a   Yuan, Jin Qing ^a   Huang, Yi Ling ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

C reactive protein; Coronary artery disease; Hyperlipidemia; Interleukin 6; Lipid profile; Statin

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; PRAVASTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644692289     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.10.021     Document Type: Article

References (26)

1. R.R. Azar, D.D. Waters, and B. Lebanon PRINCE's prospects: statin, inflammation, and coronary risk Am Heart J 141 2001 881 883
2. J.-J. Li, and X-J. Chen Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein as well as lipopolysaccharide Coron Artery Dis 14 2003 329 334
3. J.-J. Li, M.-Z. Chen, and X. Chen Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypercholesterolemia Clin Cardiol 26 2003 472 476
4. L. Diomede, D. Abain, and M. Scttocorno In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products Arterioscler Thromb Vasc Biol 21 2001 1327 1332
5. M. Kimura, I. Kurose, and J. Rusell Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats Arterioscler Thromb Vasc Biol 17 1997 1521 1526
6. T.J. Stalker, A.M. Lefer, and R. Scalla A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid Br J Pharmacol 133 2001 406 412
7. C.P. Sparrow, C.A. Burton, and M. Hernandez Simvastatin has anti-inflammatory and anti-atherosclerotic activities independent of plasma cholesterol lowering Arterioscler Thromb Vasc Biol 21 2001 115 121
8. C. Heeschen, C.W. Hamm, and U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndrome Circulation 105 2002 1446 1452
9. F.A. Spencer, G.C. Fonarow, and P.D. Freiderich Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction Arch Intern Med 164 2004 2162 2168
10. U. Laufs, M. Endres, and F. Custodis Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription Circulation 102 2000 3104 3110
11. C. Vecchione, and R.P. Brandes Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors oxidative stress and induces endothelial dysfunction in mice Circ Res 91 2002 173 179
12. K. Gertz, U. Laufs, and U. Lindauer Withdrawal of statin treatment abrogates stroke protection in mice Stroke 34 2003 551 557
13. W.-T. Lai, K.-T. Lee, and C.-H. Chu Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation Int J Cardiol 98 2005 459 464
14. L. Puccetti, A.L. Pasqui, and M. Pastorelli Platelet hyperactivity after statin treatment discontinuation Thromb Haemost 90 2003 476 482
15. K.-T. Lee, W.-T. Lai, and C.-S. Chu Effect of withdrawal of statin on C-reactive protein Cardiology 102 2004 166 170
16. A. Maseri Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the noon N Engl J Med 336 1997 1014 1016
17. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
18. J.-J. Li, and H.-R. Wang Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina Clin Chim Acta 22:352 2004 127 133
19. J.-J. Li, G.-S. Li, C.-H. Fang, and M.-Z. Chen Activation of nuclear factor-κB and correlation with elevated plasma C-reactive protein in patients with unstable angina Heat Lung Circ 13 2004 173 178
20. T. Sato, S. Takebayashi, and K. Kohehi Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina Atherosclerosis 68 1995 191 197
21. J.-J. Li Inflammation: an important mechanism for different clinical entities of coronary artery disease Chin Med J 118 21 2005 1817 1826
22. H.-R. Wang, J.-J. Li, and C.-X. Huang Fluvastatin inhibits the expression of tumor necrosis factor-α and activation of nuclear factor-κB in endothelial cells stimulated by C-reactive protein Clin Chim Acta 353 2005 53 60
23. J.-J. Li, and C.-H. Fang Effect of a single high-dose of simvastatin on C-reactive protein in patients with unstable angina Heart Drug 5 2004 140 145
24. Li, J-J, Fang, C-H, Qian, H-Y, et al. Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina. Angiology in press.
25. M.A. Marggard, B. Ke, and T. Wang Effects of pravastatin on chronic rejection of rat cardiac allografts Transplantation 65 1998 149 155
26. J.-J. Li, and C.-H. Fang C-reactive protein is not only a marker but also direct cause of cardiovascular disease Med Hypotheses 62 2004 499 506